APA

Alvarez R. H., Booser D. J., Cristofanilli M., Sahin A. A., Strom E. A., Guerra L., Kau S., Gonzalez-Angulo A. M., Hortobagyi G. N. & Valero V. (20100319). Phase 2 trial of primary systemic therapy with doxorubicin and docetaxel followed by surgery, radiotherapy, and adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil based on clinical and pathologic response in patients with stage IIB to III breast cancer : long-term results from the University of Texas M. D. Anderson Cancer Center Study ID97-099. : Cancer.

Chicago

Alvarez Ricardo H, Booser Daniel J, Cristofanilli Massimo, Sahin Aysegul A, Strom Eric A, Guerra Laura, Kau Shu-Wan, Gonzalez-Angulo Ana M, Hortobagyi Gabriel N and Valero Vicente. 20100319. Phase 2 trial of primary systemic therapy with doxorubicin and docetaxel followed by surgery, radiotherapy, and adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil based on clinical and pathologic response in patients with stage IIB to III breast cancer : long-term results from the University of Texas M. D. Anderson Cancer Center Study ID97-099. : Cancer.

Harvard

Alvarez R. H., Booser D. J., Cristofanilli M., Sahin A. A., Strom E. A., Guerra L., Kau S., Gonzalez-Angulo A. M., Hortobagyi G. N. and Valero V. (20100319). Phase 2 trial of primary systemic therapy with doxorubicin and docetaxel followed by surgery, radiotherapy, and adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil based on clinical and pathologic response in patients with stage IIB to III breast cancer : long-term results from the University of Texas M. D. Anderson Cancer Center Study ID97-099. : Cancer.

MLA

Alvarez Ricardo H, Booser Daniel J, Cristofanilli Massimo, Sahin Aysegul A, Strom Eric A, Guerra Laura, Kau Shu-Wan, Gonzalez-Angulo Ana M, Hortobagyi Gabriel N and Valero Vicente. Phase 2 trial of primary systemic therapy with doxorubicin and docetaxel followed by surgery, radiotherapy, and adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil based on clinical and pathologic response in patients with stage IIB to III breast cancer : long-term results from the University of Texas M. D. Anderson Cancer Center Study ID97-099. : Cancer. 20100319.